Abstract:The aim of this study was to investigate the incidence, risk factors of acute renal failure (ARF) after allogeneic hematopoietic stem cell transplantation (allo-HSCT), and evaluate its effect on the prognosis of patients after allo-HSCT. A retrospective analysis was performed in 86 patients undergoing allo-HSCT at Peking University First Hospital from June 2003 to April 2007. ARF is defined as a doubling of baseline serum creatinine at any time during the first 100 days post-transplant. The risks of ARF and mortality after ARF were examined using univariate analysis and multivariate unconditional logistic regression. The correlation of ARF and survival was examined using Cox regression. The results indicated that 27 patients (31.40%) developed ARF at a median of 59.5 days after transplant (range 1 to 93 days). The univariate analysis showed that elevated risks were severe acute GVHD (OR 6.196; 95% CI 1.121 - 34.249, p = 0.033), sepsis or septic shock (OR 4.184; 95% CI 1.314 - 13.325, p = 0.018) and hyperbilirubinemia (OR 3.709; 95% CI 1.428 - 9.635, p = 0.006). Renal disease before transplant (OR 6.711; 95% CI 1.199 - 37.564, p = 0.027), hypertension (OR 2.067; 95% CI 0.739 - 5.782, p = 0.165), the use of vancomycin (OR 2.133; 95% CI 0.844 - 5.392, p = 0.106) or foscarnet sodium (OR 2.133; 95% CI 0.844 - 5.392, p = 0.106) may be potential risks. Multivariate logistic regression analysis showed that renal disease before transplant (OR 6.288; 95% CI 1.218 - 32.455, p = 0.028), sepsis or septic shock (OR 3.614; 95% CI 1.040 - 12.544, p = 0.043) and hyperbilirubinemia (OR 4.448; 95% CI 1.563 - 12.665, p = 0.005) appear to be independently associated with an increased risk of ARF. Age, gender, baseline serum creatinine level, advanced malignant disease, unrelated-donor, total body irradiation (TBI) and cyclosporine levels were not associated with the development of ARF. Cox regression showed that ARF (RR 2.124; 95% CI 1.016 - 4.441, p = 0.045) was independently associated with survival of patients after allo-HSCT. The mortality of patients with ARF within 6 months post-transplant was significantly higher than that of those without ARF (44.4% vs 8.47%, p < 0.001). It is concluded that the cumulative incidence of ARF after allo-HSCT remains high. Renal disease before transplant, hyperbilirubinemia and sepsis or septic shock are all related factors which can increase the risk of ARF. ARF appears to be independent factor influencing survival of patients after allo-HSCT.

[Causes and characteristics of pre-engraftment mortality after allogeneic hematopoietic stem cell transplantation]

Clinical Characteristics and Prognostic Factors of Nephrotic Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Characteristics and Risk Factors of Intracranial Hemorrhage in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation.

Intracranial Hemorrhage and Mortality in 1461 Patients after Allogeneic Hematopoietic Stem Cell Transplantation for 6-Year Follow-Up: Study of 44 Cases

Clinical Characteristics, Microbiology, and Risk Factors for Mortality of Pre-Engraftment and Post-Engraftment Bloodstream Infection in Hematopoietic Stem Cell Transplantation Recipients.

Risk factors and predictive model for mortality in patients undergoing allogeneic hematopoietic stem cell transplantation admitted to the intensive care unit

Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors

[Clinical Analysis of Acute Renal Failure after Allogeneic Hematopoietic Stem Cell Transplantation].

Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation

Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation

Incidence, Risk Factors, Microbiology and Outcomes of Pre-engraftment Bloodstream Infection after Haploidentical Hematopoietic Stem Cell Transplantation and Comparison with HLA-identical Sibling Transplantation

Factors Influencing Engraftment in Hematological Patients after Human Leukocyte Antigen Matched Sibling Allogeneic Blood and Marrow Transplantation

Reactivation of cytomegalovirus and bloodstream infection and its impact on early survival after allogeneic haematopoietic stem cell transplantation: a multicentre retrospective study

[Analysis of Risk Factors Related to the Prognosis in Patients with Late-Onset Severe Pneumonia after Allogeneic Hematopoietic Stem Cell Transplantation].

Impact of Pre-Transplantation Characteristics on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies: a Retrospective Analysis of 100 Cases

[Hematopoietic Reconstitution on the Prognosis of Hematological Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation].

Risk factors for in-hospital mortality in recipients of allogeneic hematopoietic stem cell transplantation with acute respiratory distress syndrome: a retrospective study based on the 2023 new definition of acute respiratory distress syndrome

Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantation

Predicting Short‐term and Long‐term Mortalities from Sepsis in Patients Who Receive Allogeneic Haematopoietic Stem Cell Transplantation

[Clinical Characteristics of Late-Onset Severe Pneumonia after Allogeneic Hematopoietic Stem Cell Transplantation].

A clinical analysis of infection during agranulocytosis period after hematopoietic stem cell transplantation